Teva filled Biologics License Application for reslizumab
Posted on17 Jun 2015
TagsBREATH clinical trial programme, reslizumab, Teva, Teva filled Biologics License Application for reslizumab
Comments0
The US Food and Drug Administration (FDA) has accepted for review Teva Pharmaceutical’s Biologics License Application (BLA) for reslizumab, the company’s investigational... Read More